Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 08, 2001	PRES14A	A preliminary proxy statement giving notice regarding a special meeting	View HTML 0000950123-01-508078.pdf
Oct 12, 2001	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-01-507177.pdf
Oct 12, 2001	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-01-507186.pdf
Aug 13, 2001	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-01-505460.pdf
May 17, 2001	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0000950123-01-502703.pdf
May 11, 2001	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-01-502280.pdf
Apr 30, 2001	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000950123-01-501439.pdf
Apr 10, 2001	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000902219-01-500002.pdf
Apr 02, 2001	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001015402-01-500576.pdf
Mar 22, 2001	SC 13D/A	An amendment to a SC 13D filing	View HTML 0000898430-01-000993.pdf

Data provided by Kaleidoscope.

Investors & Media